Cellectis (CLLS) Return on Sales (2016 - 2023)
Historic Return on Sales for Cellectis (CLLS) over the last 9 years, with Q4 2023 value amounting to 17.78%.
- Cellectis' Return on Sales rose 179600.0% to 17.78% in Q4 2023 from the same period last year, while for Dec 2023 it was 17.78%, marking a year-over-year increase of 185900.0%. This contributed to the annual value of 0.6% for FY2022, which is 1400.0% up from last year.
- According to the latest figures from Q4 2023, Cellectis' Return on Sales is 17.78%, which was up 179600.0% from 0.34% recorded in Q3 2023.
- In the past 5 years, Cellectis' Return on Sales registered a high of 73.5% during Q2 2023, and its lowest value of 33.75% during Q1 2023.
- Moreover, its 5-year median value for Return on Sales was 3.25% (2019), whereas its average is 3.69%.
- Over the last 5 years, Cellectis' Return on Sales had its largest YoY gain of 738400bps in 2023, and its largest YoY loss of -298800bps in 2023.
- Cellectis' Return on Sales (Quarter) stood at 8.7% in 2019, then soared by 67bps to 2.87% in 2020, then soared by 77bps to 0.65% in 2021, then skyrocketed by 72bps to 0.18% in 2022, then surged by 10072bps to 17.78% in 2023.
- Its Return on Sales was 17.78% in Q4 2023, compared to 0.34% in Q3 2023 and 73.5% in Q2 2023.